United States

Who we are

  • April 5, 2022
    PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors
  • April 5, 2022
    Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
  • April 5, 2022
    Proton Therapy in the Treatment of Liver Metastases
  • April 5, 2022
    Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
  • April 5, 2022
    Study of DCC-3014 in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
  • April 5, 2022
    Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1
  • April 5, 2022
    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
  • April 5, 2022
    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
  • April 5, 2022
    Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer
  • April 5, 2022
    A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer (BREAKWATER)